China Digest: SoftBank-backed New Horizon Health closes Series C; LyncMed raises $20m

China Digest: SoftBank-backed New Horizon Health closes Series C; LyncMed raises $20m

New Horizon Health, a Chinese early-stage cancer screening developer, has secured $66 million in a series C funding round while medical device e-commerce platform LyncMed has raised $20 million in a series B+1 round.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter